About
Imperial College London Diabetes Centre (ICLDC), a M42 partner, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness.
Imperial College London Diabetes Centre (ICLDC), a M42 partner, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness.
Imperial College London Diabetes Centre (ICLDC), a M42 partner, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness.
Learn MoreM42 is an Abu Dhabi-based, global tech-enabled health company. It combines G42 Healthcare’s unique medical and data-centric technologies with Mubadala Health’s world-class patient services and state-of-the-art facilities to provide the highest level of personalized, precise, and preventative care.
Learn More
Meet our leadership team piloting Imperial College London Diabetes Centre’s strategic and operational objectives.
Learn MoreFirst launched in 2009, the Imperial College London Diabetes Centre’s Outcomes Report is a brief, engaging overview of our achievements for the fiscal year and reflects our commitment to provide the latest updates in our efforts to monitor and measure performance around the multi-disciplinary care provided to each of the patients we serve.
Our patients come first, this is the focus of all our activities. Our responsibility is to provide the highest standards of clinical excellence, medical care and outcomes for each and every patient.
Learn MoreOur Quality Management System provides guidance and resources to ensure that we are continually compliant with the highest healthcare quality and patient safety standards set by local and international regulatory authorities.
We partner with multiple
insurance companies
Find locations to HQ and
all our centers
We offer a comprehensive
range of diabetes and related services.
Get In Touch with Us
